+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Denosumab Injection Market - Global Forecast 2025-2030- Product Image
Denosumab Injection Market - Global Forecast 2025-2030- Product Image
Sale

Denosumab Injection Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131748
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Denosumab Injection is reshaping treatment protocols in bone health and oncology by offering a biologic solution that enhances patient outcomes and operational efficiency across care settings. Its rapid adoption stems from its tailored applications in osteoporosis and cancer-related bone conditions, establishing it as a strategic asset in hospital, clinic, and pharmacy practice.

Market Snapshot: Denosumab Injection Market

The global Denosumab Injection market is evolving rapidly due to breakthrough advances in molecular science, expanded clinical indications, and improvements in healthcare delivery models. Increasing demand is driven by heightened focus on bone health management in postmenopausal women and oncology patients with metastases or myeloma, alongside growing preference for injectable biologics that support both adherence and streamlined clinical workflows. Recent years have seen multiple product label expansions and regulatory authorizations, positioning Denosumab Injection in a prominent role among other RANKL inhibitors and biologic therapies.

Scope & Segmentation

This report provides an in-depth analysis of the Denosumab Injection market, outlining major segments and covering detailed geographic and company-specific trends. The workflow and adoption patterns are divided across several axes:

  • Applications: Bone metastases (breast, lung, prostate cancer), multiple myeloma, postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, male osteoporosis
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • End Users: Clinics, home healthcare, hospitals
  • Dosage Strengths: 120 mg monthly, 60 mg every six months
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Amgen Inc., Viatris Inc., Biocon Ltd., Sandoz International GmbH, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Zydus Cadila Healthcare Ltd., Qilu Pharmaceutical Co., Ltd., Alkem Laboratories Ltd.

Key Takeaways for Senior Decision-Makers

  • Denosumab Injection’s activity as a RANKL-targeted biologic offers differentiated value across osteoporosis and oncology indications, allowing tailored therapeutic regimens and better alignment with patient risk profiles.
  • Healthcare system transformations, including digital health integration and self-administration devices, are enhancing adherence and reducing clinical burdens, especially in remote and home-based care.
  • Operational resilience is strengthened by strategies such as domestic fill-finish partnerships and contract manufacturing collaborations, which mitigate supply disruptions and optimize cost containment amid shifting tariff environments.
  • Market segmentation reveals that hospital channels dominate oncology care, while self-administering osteoporosis patients are more likely to seek fulfillment via online and retail pharmacies, supporting varied marketing and support programs.
  • Emerging biosimilars and second-generation RANKL inhibitors are intensifying competition, with companies leveraging real-world evidence, temperature-control innovations, and clinical trial differentiation to secure payer confidence and market access.

Tariff Impact: US Policies Reshape Strategic Priorities

United States tariffs on biologic imports have impacted cost structures across the Denosumab Injection supply chain. Manufacturers dependent on international sourcing have responded by pursuing joint ventures, expanding domestic production, and leveraging bulk procurement to stabilize pricing. These measures facilitate supply continuity and help providers maintain access despite cost fluctuations, supporting more robust reimbursement negotiations and formulary review processes.

Methodology & Data Sources

This analysis is grounded in primary interviews with clinicians, payers, and patient advocacy groups, paired with secondary research from peer-reviewed publications, regulatory filings, and procurement databases. Quantitative modeling assessed tariff sensitivities and pricing inputs, with all findings subjected to cross-verification and rigorous data triangulation.

Why This Report Matters

  • Enables strategic positioning by clarifying growth drivers and coverage trends across applications, distribution settings, and regions for Denosumab Injection.
  • Supports investment and partnership decisions through actionable segmentation insights and competitor intelligence drawn from leading innovators and biosimilar entrants.
  • Helps stakeholders anticipate and navigate policy, economic, and technological shifts impacting patient access and reimbursement.

Conclusion

Denosumab Injection’s market trajectory is defined by scientific progress, adaptive delivery models, and responsive policy strategies. Decision-makers can leverage these insights to strengthen their market approach, ensuring optimized access, compliance, and patient-centric care within an increasingly complex global ecosystem.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of home administration programs for denosumab to enhance patient convenience and adherence
5.2. Development of next-generation biosimilars targeting denosumab to address patent expirations and cost pressures
5.3. Integration of digital health monitoring tools to track patient response and adverse effects with denosumab therapy
5.4. Emergence of novel delivery systems such as sustained-release implants for denosumab to improve dosing frequency
5.5. Increased investment in combination therapies pairing denosumab with novel oncology agents for bone metastasis management
5.6. Expansion of real-world evidence studies evaluating long-term safety and efficacy of denosumab in osteoporosis patients
5.7. Growing focus on pediatric applications of denosumab for skeletal disorders in rare disease populations
5.8. Regulatory pathway advancements for denosumab in emerging markets to accelerate market penetration and uptake
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Denosumab Injection Market, by Application
8.1. Introduction
8.2. Bone Metastases
8.2.1. Breast Cancer
8.2.2. Lung Cancer
8.2.3. Prostate Cancer
8.3. Multiple Myeloma
8.4. Osteoporosis
8.4.1. Glucocorticoid Induced
8.4.2. Male
8.4.3. Postmenopausal
9. Denosumab Injection Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Denosumab Injection Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Healthcare
10.4. Hospitals
11. Denosumab Injection Market, by Dosage Strength
11.1. Introduction
11.2. 120 Mg
11.2.1. Every Monthly
11.3. 60 Mg
11.3.1. Every Six Months
12. Americas Denosumab Injection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Denosumab Injection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Denosumab Injection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Amgen Inc.
15.3.2. Viatris Inc.
15.3.3. Biocon Ltd.
15.3.4. Sandoz International GmbH
15.3.5. Dr. Reddy’s Laboratories Ltd.
15.3.6. Intas Pharmaceuticals Ltd.
15.3.7. Cipla Ltd.
15.3.8. Zydus Cadila Healthcare Ltd.
15.3.9. Qilu Pharmaceutical Co., Ltd.
15.3.10. Alkem Laboratories Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DENOSUMAB INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DENOSUMAB INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DENOSUMAB INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DENOSUMAB INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DENOSUMAB INJECTION MARKET: RESEARCHAI
FIGURE 24. DENOSUMAB INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 25. DENOSUMAB INJECTION MARKET: RESEARCHCONTACTS
FIGURE 26. DENOSUMAB INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DENOSUMAB INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DENOSUMAB INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DENOSUMAB INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY GLUCOCORTICOID INDUCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY GLUCOCORTICOID INDUCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY POSTMENOPAUSAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY POSTMENOPAUSAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY EVERY MONTHLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY EVERY MONTHLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY EVERY SIX MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY EVERY SIX MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES DENOSUMAB INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 102. CANADA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 103. CANADA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 104. CANADA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 105. CANADA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. CANADA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. CANADA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 110. CANADA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 111. CANADA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 112. CANADA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 113. CANADA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 114. CANADA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 115. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 118. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 119. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 126. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 127. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 128. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 129. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 130. MEXICO DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DENOSUMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 197. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 200. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 201. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 210. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 211. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 212. GERMANY DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 213. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 216. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 217. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 218. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 219. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 226. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 227. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 228. FRANCE DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 245. ITALY DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. ITALY DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 248. ITALY DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 249. ITALY DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 250. ITALY DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 251. ITALY DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ITALY DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ITALY DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ITALY DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 256. ITALY DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 257. ITALY DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 258. ITALY DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 259. ITALY DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 260. ITALY DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 261. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 264. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 265. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 266. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 267. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 274. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 275. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 276. SPAIN DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 325. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 328. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2025-2030 (USD MILLION)
TABLE 329. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2018-2024 (USD MILLION)
TABLE 330. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY OSTEOPOROSIS, 2025-2030 (USD MILLION)
TABLE 331. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 336. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 337. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2018-2024 (USD MILLION)
TABLE 338. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY 120 MG, 2025-2030 (USD MILLION)
TABLE 339. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2018-2024 (USD MILLION)
TABLE 340. DENMARK DENOSUMAB INJECTION MARKET SIZE, BY 60 MG, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS DENOSUMAB INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS DENOSUMAB INJECTION MARKET SIZE, BY BONE METASTASES, 2018-2024 (USD MILLION)
TABLE 34

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Denosumab Injection market report include:
  • Amgen Inc.
  • Viatris Inc.
  • Biocon Ltd.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Intas Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Zydus Cadila Healthcare Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Alkem Laboratories Ltd.

Related Topics

Related Reports

Denosumab Market Report 2025 - Product Image

Denosumab Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Osteoporosis Drugs Market - Global Forecast 2025-2030 - Product Image

Osteoporosis Drugs Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review - Product Image

Denosumab (Prolia & Xgeva) Biosimilars Pipeline Review

  • Report
  • Global
From
Recombinant Teriparatide for Injection Market - Global Forecast 2025-2030 - Product Image

Recombinant Teriparatide for Injection Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Calcitonin Injection Global Market Report 2025 - Product Image

Calcitonin Injection Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.